oxaprozin has been researched along with Adamantiades-Behcet Disease in 2 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, A | 2 |
| Mori, M | 2 |
| Hashimoto, A | 2 |
| Chihara, T | 2 |
2 other studies available for oxaprozin and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
Efficacy of oxaprozin in the treatment of articular symptoms of Behçet's disease.
Topics: Adult; Anti-Inflammatory Agents; Arthritis; Behcet Syndrome; Female; Humans; Male; Middle Aged; Oxap | 1984 |
[Efficacy of oxaprozin in the treatment of articular symptoms of Behçet's disease].
Topics: Adult; Anti-Inflammatory Agents; Arthritis; Behcet Syndrome; Female; Humans; Male; Middle Aged; Oxap | 1985 |